ConductScience.org, home

Paper528373

Tetrahydropyranyl derivatives of daunomycin and adriamycin.

Umezawa H and 7 others. J Antibiot (Tokyo), 1979. Cited by 176 papers, by iCite.

Cite this record

ConductScience Library. Tetrahydropyranyl derivatives of daunomycin and adriamycin. Papers, record 528373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/528373

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tetrahydropyranyl derivatives of daunomycin and adriamycin.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
176
iCite
Relative citation ratio, by iCite
6.02
iCite
Revised in PubMed
2019-07-23
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Umezawa HH
2Takahashi YY
3Kinoshita MM
4Naganawa HH
5Masuda TT
6Ishizuka MM
7Tatsuta KK
8Takeuchi TT

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DaunorubicinMajor topic
DoxorubicinMajor topic
Animals
Antibiotics, Antineoplastic
Leukemia L1210
Mice

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 176 citations.

PMIDTitleJournalYearIn PapersSource
41872646Mechanistic Insights into pH-Responsive Drug Release and Antitumor Effects of an Albumin-Pirarubicin Conjugate.Pharm Res2026https://conductscience.org/library/papers/41872646PubMed
41514559Systemic Chemotherapy in Penile Squamous Cell Carcinoma: Mechanisms, Clinical Applications, and Evidence-Based Regimens.Cancers (Basel)2025https://conductscience.org/library/papers/41514559PubMed
40205399
Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus Calmette-Guérin in the treatment of patients with high-risk non-muscle-invasive bladder carcinoma: a retrospective study.
BMC Urol2025https://conductscience.org/library/papers/40205399PubMed
40024743Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen.J Clin Exp Hematop2025https://conductscience.org/library/papers/40024743PubMed
39941040Design of New Daunorubicin Derivatives with High Cytotoxic Potential.Int J Mol Sci2025https://conductscience.org/library/papers/39941040PubMed
37238419Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report.Children (Basel)2023https://conductscience.org/library/papers/37238419PubMed
37205905Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study.Front Pharmacol2023https://conductscience.org/library/papers/37205905PubMed
36575000A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.J Clin Exp Hematop2022https://conductscience.org/library/papers/36575000PubMed
34193755A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma.J Clin Exp Hematop2021https://conductscience.org/library/papers/34193755PubMed
33864237
Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.
Int J Hematol2021https://conductscience.org/library/papers/33864237PubMed
33396604Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33396604PubMed
32907549Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis.BMC Cancer2020https://conductscience.org/library/papers/32907549PubMed
31138757Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway.Biosci Rep2019https://conductscience.org/library/papers/31138757PubMed
288240573A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.Intern Med2017https://conductscience.org/library/papers/28824057PubMed
27858183Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.Int J Clin Oncol2017https://conductscience.org/library/papers/27858183PubMed
25529761Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.Cancer Sci2015https://conductscience.org/library/papers/25529761PubMed
25432694Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?Med Oncol2015https://conductscience.org/library/papers/25432694PubMed
22580740Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest.Acta Pharmacol Sin2012https://conductscience.org/library/papers/22580740PubMed
20033628Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience.Int J Hematol2010https://conductscience.org/library/papers/20033628PubMed
19707675Synthesis and DNA-binding affinity studies of glycosylated intercalators designed as functional mimics of the anthracycline antibiotics.Org Biomol Chem2009https://conductscience.org/library/papers/19707675PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/528373

GET https://conductscience.org/api/papers/v1/528373/cited_by?page=2